Dexmethylphenidate Hydrochloride 75834-0327-01
- Manufacturer
- Nivagen Pharmaceuticals, Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 3, 2024
- Listing Expires
- December 31, 2027
- Application
- ANDA209211
Active Ingredients
| Ingredient | Strength |
|---|---|
| Dexmethylphenidate Hydrochloride | 5 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
75834-0327-01Selected100 TABLET in 1 BOTTLE (75834-327-01)